NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Press Enter or click the Search button to begin your search.

Back to Results
Space Biotech: Hindsight, Insight, ForesightOver the past forty years, microgravity has inspired and enabled applications in a wide range of sectors including medicine, materials, computers, communications, and national defense. Trends show that demand for high-tech solutions is increasing in these sectors, solutions that require higher resolution, greater precision, novel materials, innovative processes, and more sophisticated tools. These are areas where microgravity can offer unique capabilities for innovation. The Emerging Space Office (ESO) has engaged in multiple studies over the past year that have found that microgravity RD is one of the most promising technology areas for contributing to economic growth and to NASAs mission. The focus of these studies was on terrestrial markets rather than NASA applications, applied research rather than basic research, and commercial rather than academic investigators. There have been more success stories than are generally appreciated and there are significant areas of promising future potential. Many of the problems that have limited commercial microgravity development in the past are being solved. Microgravity research and development (RD) requires iteration and learning, as rapidly as possible. New technologies enable high throughput and rapid data collection in increasingly small payloads. The International Space Station is in orbit and provides a laboratory that is available 247 at least until 2024. Frequent flights by commercial space providers to and from the ISS now enable the fast learning cycles needed by high-tech industries. Launch costs are decreasing and the ability to return payloads to Earth is increasing. New commercial space laboratories, such as those being developed by SpaceX and Bigelow Aerospace, are in the final stages of development and testing. This ecosystem for microgravity RD has never been available before. These are game-changer conditions for attracting high-tech industries to space for terrestrial, as well as NASA, applications. However, few know that these capabilities are available or how to use them. In aggregate, the potential value for new applications from microgravity RD over the next ten years could add billions of dollars per year in terrestrial applications to the future economy, create new jobs, and generate a wide range of public benefits in medical advances, while broadening the customer base for the emerging space industry.
Document ID
20150022148
Acquisition Source
Ames Research Center
Document Type
Presentation
Authors
Harper, Lynn
(NASA Ames Research Center Moffett Field, CA United States)
Date Acquired
December 2, 2015
Publication Date
May 20, 2015
Subject Category
Life Sciences (General)
Report/Patent Number
ARC-E-DAA-TN22743
Report Number: ARC-E-DAA-TN22743
Meeting Information
Meeting: ExoMed Conference 2015
Location: Swampscott, MA
Country: United States
Start Date: May 20, 2015
Sponsors: Kentucky Space
Funding Number(s)
WBS: WBS 868334.01.01.01
Distribution Limits
Public
Copyright
Work of the US Gov. Public Use Permitted.
Keywords
biotech
commercial space
medicine
space medicine
commercial space
No Preview Available